{
  "DOI": "10.1007/s00439-023-02628-z",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-023-02628-z",
  "alternative-id": [
    "2628"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "16 February 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "24 November 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "30 December 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Authors declare no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Abouelhoda",
      "given": "Mohamed",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Almuqati",
      "given": "Noura",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Abogosh",
      "given": "Ahmed",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alfraih",
      "given": "Feras",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2999-2229",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Maddirevula",
      "given": "Sateesh",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alkuraya",
      "given": "Fowzan S.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        12,
        30
      ]
    ],
    "date-time": "2023-12-30T07:02:02Z",
    "timestamp": 1703919722000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        2,
        21
      ]
    ],
    "date-time": "2024-02-21T12:06:48Z",
    "timestamp": 1708517208000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        22
      ]
    ],
    "date-time": "2024-02-22T00:34:54Z",
    "timestamp": 1708562094691
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2023,
        12,
        30
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2024,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            12,
            30
          ]
        ],
        "date-time": "2023-12-30T00:00:00Z",
        "timestamp": 1703894400000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            12,
            30
          ]
        ],
        "date-time": "2023-12-30T00:00:00Z",
        "timestamp": 1703894400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-023-02628-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s00439-023-02628-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-023-02628-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "125-136",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        12,
        30
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        12,
        30
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2024,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1186/s13073-021-01003-9",
      "author": "AN Abou Tayoun",
      "doi-asserted-by": "publisher",
      "first-page": "184",
      "journal-title": "Genome Med",
      "key": "2628_CR1",
      "unstructured": "Abou Tayoun AN, Fakhro KA, Alsheikh-Ali A, Alkuraya FS (2021) Genomic medicine in the Middle East. Genome Med 13:184. https://doi.org/10.1186/s13073-021-01003-9",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s40246-022-00378-z",
      "author": "M Alali",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "Hum Genom",
      "key": "2628_CR2",
      "unstructured": "Alali M, Ismail Al-Khalil W, Rijjal S, Al-Salhi L, Saifo M, Youssef LA (2022) Frequencies of CYP2D6 genetic polymorphisms in Arab populations. Hum Genom 16:6. https://doi.org/10.1186/s40246-022-00378-z",
      "volume": "16",
      "year": "2022"
    },
    {
      "DOI": "10.1167/iovs.08-3006",
      "author": "MA Aldahmesh",
      "doi-asserted-by": "publisher",
      "first-page": "4142",
      "journal-title": "Invest Ophthalmol vis Sci",
      "key": "2628_CR3",
      "unstructured": "Aldahmesh MA, Khan AO, Meyer BF, Alkuraya FS (2009) Mutational spectrum of SLC4A11 in autosomal recessive CHED in Saudi Arabia. Invest Ophthalmol vis Sci 50:4142–4145. https://doi.org/10.1167/iovs.08-3006",
      "volume": "50",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.etap.2013.09.008",
      "author": "MS Al-Dosari",
      "doi-asserted-by": "publisher",
      "first-page": "1063",
      "journal-title": "Environ Toxicol Pharmacol",
      "key": "2628_CR4",
      "unstructured": "Al-Dosari MS, Al-Jenoobi FI, Alkharfy KM, Alghamdi AM, Bagulb KM, Parvez MK, Al-Mohizea AM, Al-Muhsen S, Halwani R (2013) High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians. Environ Toxicol Pharmacol 36:1063–1067. https://doi.org/10.1016/j.etap.2013.09.008",
      "volume": "36",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.humimm.2020.12.006",
      "author": "F Alfraih",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Hum Immunol",
      "key": "2628_CR5",
      "unstructured": "Alfraih F, Alawwami M, Aljurf M, Alhumaidan H, Alsaedi H, El Fakih R, Alotaibi B, Rasheed W, Bernas SN, Massalski C (2021) High-resolution HLA allele and haplotype frequencies of the Saudi Arabian population based on 45,457 individuals and corresponding stem cell donor matching probabilities. Hum Immunol 82:97–102",
      "volume": "82",
      "year": "2021"
    },
    {
      "DOI": "10.1111/j.1742-7843.2012.00919.x",
      "author": "FI Al-Jenoobi",
      "doi-asserted-by": "publisher",
      "first-page": "50",
      "journal-title": "Basic Clin Pharmacol Toxicol",
      "key": "2628_CR6",
      "unstructured": "Al-Jenoobi FI, Alkharfy KM, Alghamdi AM, Bagulb KM, Al-Mohizea AM, Al-Muhsen S, Halwani R, Parvez MK, Al-Dosari MS (2013) CYP2C19 genetic polymorphism in Saudi Arabians. Basic Clin Pharmacol Toxicol 112:50–54. https://doi.org/10.1111/j.1742-7843.2012.00919.x",
      "volume": "112",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.sjbs.2019.11.007",
      "author": "FI Al-Saikhan",
      "doi-asserted-by": "publisher",
      "first-page": "456",
      "journal-title": "Saudi J Biol Sci",
      "key": "2628_CR7",
      "unstructured": "Al-Saikhan FI (2020) Genetic risk assessment towards warfarin application: Saudi Arabia study with a potential to predict and prevent side effects. Saudi J Biol Sci 27:456–459. https://doi.org/10.1016/j.sjbs.2019.11.007",
      "volume": "27",
      "year": "2020"
    },
    {
      "DOI": "10.1002/ajh.2830420111",
      "author": "E Beutler",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "journal-title": "Am J Hematol",
      "key": "2628_CR8",
      "unstructured": "Beutler E (1993a) Study of glucose-6-phosphate dehydrogenase: history and molecular biology. Am J Hematol 42:53–58. https://doi.org/10.1002/ajh.2830420111",
      "volume": "42",
      "year": "1993"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2019.5345",
      "author": "C Chanfreau-Coffinier",
      "doi-asserted-by": "publisher",
      "first-page": "e195345",
      "journal-title": "JAMA Netw Open",
      "key": "2628_CR9",
      "unstructured": "Chanfreau-Coffinier C, Hull LE, Lynch JA, DuVall SL, Damrauer SM, Cunningham FE, Voight BF, Matheny ME, Oslin DW, Icardi MS (2019) Projected prevalence of actionable pharmacogenetic variants and level A drugs prescribed among US Veterans Health Administration pharmacy users. JAMA Netw Open 2:e195345–e195345",
      "volume": "2",
      "year": "2019"
    },
    {
      "DOI": "10.1056/NEJMoa1009717",
      "author": "P Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1126",
      "journal-title": "N Engl J Med",
      "key": "2628_CR10",
      "unstructured": "Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY, Taiwan SJSC (2011) Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 364:1126–1133. https://doi.org/10.1056/NEJMoa1009717",
      "volume": "364",
      "year": "2011"
    },
    {
      "DOI": "10.1056/NEJMp1500523",
      "author": "FS Collins",
      "doi-asserted-by": "publisher",
      "first-page": "793",
      "journal-title": "N Engl J Med",
      "key": "2628_CR11",
      "unstructured": "Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793–795. https://doi.org/10.1056/NEJMp1500523",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cpt.2557",
      "author": "RM Cooper-DeHoff",
      "doi-asserted-by": "publisher",
      "first-page": "1007",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2628_CR12",
      "unstructured": "Cooper-DeHoff RM, Niemi M, Ramsey LB, Luzum JA, Tarkiainen EK, Straka RJ, Gong L, Tuteja S, Wilke RA, Wadelius M, Larson EA, Roden DM, Klein TE, Yee SW, Krauss RM, Turner RM, Palaniappan L, Gaedigk A, Giacomini KM, Caudle KE, Voora D (2022) The clinical pharmacogenetics implementation consortium guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms. Clin Pharmacol Ther 111(5):1007–1021. https://doi.org/10.1002/cpt.2557",
      "volume": "111",
      "year": "2022"
    },
    {
      "DOI": "10.1371/journal.pone.0260824",
      "author": "EG Elalem",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2628_CR13",
      "unstructured": "Elalem EG, Jelani M, Khedr A, Ahmad A, Alaama TY, Alaama MN, Al-Kreathy HM, Damanhouri ZA (2022) Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients. PLoS ONE 17:e0260824. https://doi.org/10.1371/journal.pone.0260824",
      "volume": "17",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41591-021-01672-4",
      "author": "S Fatumo",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "Nat Med",
      "key": "2628_CR14",
      "unstructured": "Fatumo S, Chikowore T, Choudhury A, Ayub M, Martin AR, Kuchenbaecker K (2022) A roadmap to increase diversity in genomic studies. Nat Med 28:243–250. https://doi.org/10.1038/s41591-021-01672-4",
      "volume": "28",
      "year": "2022"
    },
    {
      "DOI": "10.1097/GIM.0b013e318163c35f",
      "author": "DA Flockhart",
      "doi-asserted-by": "publisher",
      "first-page": "139",
      "journal-title": "Genet Med",
      "key": "2628_CR15",
      "unstructured": "Flockhart DA, O’Kane D, Williams MS, Watson MS, Flockhart DA, Gage B, Gandolfi R, King R, Lyon E, Nussbaum R, O’Kane D, Schulman K, Veenstra D, Williams MS, Watson MS, Acmg Working Group on Pharmacogenetic Testing of Cyp2C VAfWU (2008) Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med 10:139–150. https://doi.org/10.1097/GIM.0b013e318163c35f",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1002/(sici)1099-1557(199710)6:3+\u003cs79::aid-pds294\u003e3.3.co;2-f",
      "author": "M Goettler",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "issue": "Suppl 3",
      "journal-title": "Pharmacoepidemiol Drug Saf",
      "key": "2628_CR16",
      "unstructured": "Goettler M, Schneeweiss S, Hasford J (1997) Adverse drug reaction monitoring—cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 6(Suppl 3):79–90. https://doi.org/10.1002/(sici)1099-1557(199710)6:3+%3cs79::aid-pds294%3e3.3.co;2-f",
      "volume": "6",
      "year": "1997"
    },
    {
      "author": "DW Haas",
      "first-page": "2391",
      "journal-title": "AIDS",
      "key": "2628_CR17",
      "unstructured": "Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, Clifford DB, Hulgan T, Marzolini C, Acosta EP (2004) Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS 18:2391–2400",
      "volume": "18",
      "year": "2004"
    },
    {
      "DOI": "10.1186/1472-6963-9-27",
      "author": "LH Hoonhout",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "BMC Health Serv Res",
      "key": "2628_CR18",
      "unstructured": "Hoonhout LH, de Bruijne MC, Wagner C, Zegers M, Waaijman R, Spreeuwenberg P, Asscheman H, van der Wal G, van Tulder MW (2009) Direct medical costs of adverse events in Dutch hospitals. BMC Health Serv Res 9:27. https://doi.org/10.1186/1472-6963-9-27",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.3390/jpm12030421",
      "author": "JP Jarvis",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "J Pers Med",
      "key": "2628_CR19",
      "unstructured": "Jarvis JP, Peter AP, Keogh M, Baldasare V, Beanland GM, Wilkerson ZT, Kradel S, Shaman JA (2022) Real-world impact of a pharmacogenomics-enriched comprehensive medication management program. J Pers Med 12:10. https://doi.org/10.3390/jpm12030421",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41397-022-00275-7",
      "author": "S Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "188",
      "journal-title": "Pharmacogenomics J",
      "key": "2628_CR20",
      "unstructured": "Jiang S, Mathias PC, Hendrix N, Shirts BH, Tarczy-Hornoch P, Veenstra D, Malone D, Devine B (2022) Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis. Pharmacogenomics J 22:188–197. https://doi.org/10.1038/s41397-022-00275-7",
      "volume": "22",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41525-022-00281-5",
      "author": "PV Jithesh",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "NPJ Genom Med",
      "key": "2628_CR21",
      "unstructured": "Jithesh PV, Abuhaliqa M, Syed N, Ahmed I, El Anbari M, Bastaki K, Sherif S, Umlai UK, Jan Z, Gandhi G, Manickam C, Selvaraj S, George C, Bangarusamy D, Abdel-Latif R, Al-Shafai M, Tatari-Calderone Z, Estivill X, Qatar Genome Program Research C (2022) A population study of clinically actionable genetic variation affecting drug response from the Middle East. NPJ Genom Med 7:10. https://doi.org/10.1038/s41525-022-00281-5",
      "volume": "7",
      "year": "2022"
    },
    {
      "DOI": "10.1038/clpt.2011.185",
      "author": "JA Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "625",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2628_CR22",
      "unstructured": "Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB, Clinical Pharmacogenetics Implementation C (2011) Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther 90:625–629. https://doi.org/10.1038/clpt.2011.185",
      "volume": "90",
      "year": "2011"
    },
    {
      "DOI": "10.1038/gim.2016.33",
      "author": "M Kozyra",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Genet Med",
      "key": "2628_CR23",
      "unstructured": "Kozyra M, Ingelman-Sundberg M, Lauschke VM (2017) Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response. Genet Med 19:20–29",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s40246-019-0229-z",
      "author": "K Krebs",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "journal-title": "Hum Genom",
      "key": "2628_CR24",
      "unstructured": "Krebs K, Milani L (2019) Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good. Hum Genom 13:39. https://doi.org/10.1186/s40246-019-0229-z",
      "volume": "13",
      "year": "2019"
    },
    {
      "DOI": "10.1111/bcp.13207",
      "author": "HH Lee",
      "doi-asserted-by": "publisher",
      "first-page": "1176",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2628_CR25",
      "unstructured": "Lee HH, Ho RH (2017) Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1). Br J Clin Pharmacol 83:1176–1184",
      "volume": "83",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41436-018-0054-0",
      "author": "S-b Lee",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "journal-title": "Genet Med",
      "key": "2628_CR26",
      "unstructured": "Lee S-b, Wheeler MM, Patterson K, McGee S, Dalton R, Woodahl EL, Gaedigk A, Thummel KE, Nickerson DA (2019) Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model. Genet Med 21:361–372",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1111/bcp.15485",
      "author": "M Lehtisalo",
      "doi-asserted-by": "publisher",
      "first-page": "242",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2628_CR27",
      "unstructured": "Lehtisalo M, Taskinen S, Tarkiainen EK, Neuvonen M, Viinamäki J, Paile-Hyvärinen M, Lilius TO, Tapaninen T, Backman JT, Tornio A (2023) A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics. Br J Clin Pharmacol 89:242–252",
      "volume": "89",
      "year": "2023"
    },
    {
      "DOI": "10.1111/bcp.14983",
      "author": "EF Magavern",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2628_CR28",
      "unstructured": "Magavern EF, Gurdasani D, Ng FL, Lee SS (2022) Health equality, race and pharmacogenomics. Br J Clin Pharmacol 88:27–33. https://doi.org/10.1111/bcp.14983",
      "volume": "88",
      "year": "2022"
    },
    {
      "DOI": "10.2217/pgs-2017-0076",
      "author": "A Martin",
      "doi-asserted-by": "publisher",
      "first-page": "1541",
      "journal-title": "Pharmacogenomics",
      "key": "2628_CR29",
      "unstructured": "Martin A, Downing J, Maden M, Fleeman N, Alfirevic A, Haycox A, Pirmohamed M (2017) An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review. Pharmacogenomics 18:1541–1550. https://doi.org/10.2217/pgs-2017-0076",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1097/FPC.0b013e32834eb313",
      "author": "EM McDonagh",
      "doi-asserted-by": "publisher",
      "first-page": "219",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2628_CR30",
      "unstructured": "McDonagh EM, Thorn CF, Bautista JM, Youngster I, Altman RB, Klein TE (2012) PharmGKB summary: very important pharmacogene information for G6PD. Pharmacogenet Genomics 22:219–228. https://doi.org/10.1097/FPC.0b013e32834eb313",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cpt.2122",
      "author": "G McInnes",
      "doi-asserted-by": "publisher",
      "first-page": "1528",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2628_CR31",
      "unstructured": "McInnes G, Lavertu A, Sangkuhl K, Klein TE, Whirl-Carrillo M, Altman RB (2021) Pharmacogenetics at scale: an analysis of the UK Biobank. Clin Pharmacol Ther 109:1528–1537. https://doi.org/10.1002/cpt.2122",
      "volume": "109",
      "year": "2021"
    },
    {
      "DOI": "10.1097/00008571-199706000-00003",
      "author": "RA McLellan",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Pharmacogenetics",
      "key": "2628_CR32",
      "unstructured": "McLellan RA, Oscarson M, Seidegard J, Evans DA, Ingelman-Sundberg M (1997) Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics 7:187–191. https://doi.org/10.1097/00008571-199706000-00003",
      "volume": "7",
      "year": "1997"
    },
    {
      "DOI": "10.2217/pgs.14.102",
      "author": "C Mizzi",
      "doi-asserted-by": "publisher",
      "first-page": "1223",
      "journal-title": "Pharmacogenomics",
      "key": "2628_CR33",
      "unstructured": "Mizzi C, Peters B, Mitropoulou C, Mitropoulos K, Katsila T, Agarwal MR, Van Schaik RH, Drmanac R, Borg J, Patrinos GP (2014) Personalized pharmacogenomics profiling using whole-genome sequencing. Pharmacogenomics 15:1223–1234",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cpt.2754",
      "author": "SA Morris",
      "doi-asserted-by": "publisher",
      "first-page": "1318",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2628_CR34",
      "unstructured": "Morris SA, Alsaidi AT, Verbyla A, Cruz A, Macfarlane C, Bauer J, Patel JN (2022) Cost effectiveness of pharmacogenetic testing for drugs with clinical pharmacogenetics implementation consortium (CPIC) guidelines: a systematic review. Clin Pharmacol Ther 112:1318–1328. https://doi.org/10.1002/cpt.2754",
      "volume": "112",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.bcmd.2008.12.005",
      "author": "ET Nkhoma",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "Blood Cells Mol Dis",
      "key": "2628_CR35",
      "unstructured": "Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42:267–278. https://doi.org/10.1016/j.bcmd.2008.12.005",
      "volume": "42",
      "year": "2009"
    },
    {
      "DOI": "10.3390/genes11050561",
      "author": "MT Pandi",
      "doi-asserted-by": "publisher",
      "journal-title": "Genes (basel)",
      "key": "2628_CR36",
      "unstructured": "Pandi MT, Williams MS, van der Spek P, Koromina M, Patrinos GP (2020) Exome-wide analysis of the DiscovEHR cohort reveals novel candidate pharmacogenomic variants for clinical pharmacogenomics. Genes (basel). https://doi.org/10.3390/genes11050561",
      "year": "2020"
    },
    {
      "DOI": "10.1097/01.fpc.0000230416.82349.90",
      "author": "MK Pasanen",
      "doi-asserted-by": "publisher",
      "first-page": "873",
      "journal-title": "Pharmacogenet Genom",
      "key": "2628_CR37",
      "unstructured": "Pasanen MK, Neuvonen M, Neuvonen PJ, Niemi M (2006) SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. Pharmacogenet Genom 16:873–879. https://doi.org/10.1097/01.fpc.0000230416.82349.90",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1101/gr.129668.111",
      "author": "LB Ramsey",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Genome Res",
      "key": "2628_CR38",
      "unstructured": "Ramsey LB, Bruun GH, Yang W, Treviño LR, Vattathil S, Scheet P, Cheng C, Rosner GL, Giacomini KM, Fan Y (2012) Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res 22:1–8",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature15817",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "343",
      "journal-title": "Nature",
      "key": "2628_CR39",
      "unstructured": "Relling MV, Evans WE (2015) Pharmacogenomics in the clinic. Nature 526:343–350. https://doi.org/10.1038/nature15817",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cpt.1651",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "171",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2628_CR40",
      "unstructured": "Relling MV, Klein TE, Gammal RS, Whirl-Carrillo M, Hoffman JM, Caudle KE (2020) The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later. Clin Pharmacol Ther 107:171–175. https://doi.org/10.1002/cpt.1651",
      "volume": "107",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41439-021-00135-z",
      "author": "C Runcharoen",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "Human Genome Variation",
      "key": "2628_CR41",
      "unstructured": "Runcharoen C, Fukunaga K, Sensorn I, Iemwimangsa N, Klumsathian S, Tong H, Vo NS, Le L, Hlaing TM, Thant M (2021) Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm). Human Genome Variation 8:7",
      "volume": "8",
      "year": "2021"
    },
    {
      "DOI": "10.1002/cpt.1720",
      "author": "R Shekhani",
      "doi-asserted-by": "publisher",
      "first-page": "1240",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2628_CR42",
      "unstructured": "Shekhani R, Steinacher L, Swen JJ, Ingelman-Sundberg M (2020) Evaluation of current regulation and guidelines of pharmacogenomic drug labels: opportunities for improvements. Clin Pharmacol Ther 107:1240–1255. https://doi.org/10.1002/cpt.1720",
      "volume": "107",
      "year": "2020"
    },
    {
      "DOI": "10.2217/pgs-2018-0146",
      "author": "A Shendre",
      "doi-asserted-by": "publisher",
      "first-page": "1357",
      "journal-title": "Pharmacogenomics",
      "key": "2628_CR43",
      "unstructured": "Shendre A, Dillon C, Limdi NA (2018) Pharmacogenetics of warfarin dosing in patients of African and European ancestry. Pharmacogenomics 19:1357–1371. https://doi.org/10.2217/pgs-2018-0146",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1038/clpt.2009.232",
      "author": "B Tomlinson",
      "doi-asserted-by": "publisher",
      "first-page": "558",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2628_CR44",
      "unstructured": "Tomlinson B, Hu M, Lee V, Lui S, Chu T, Poon E, Ko G, Baum L, Tam L, Li E (2010) ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. Clin Pharmacol Ther 87:558–562",
      "volume": "87",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41397-021-00208-w",
      "author": "S Turongkaravee",
      "doi-asserted-by": "publisher",
      "first-page": "296",
      "journal-title": "Pharmacogenomics J",
      "key": "2628_CR45",
      "unstructured": "Turongkaravee S, Jittikoon J, Lukkunaprasit T, Sangroongruangsri S, Chaikledkaew U, Thakkinstian A (2021) A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy. Pharmacogenomics J 21:296–307. https://doi.org/10.1038/s41397-021-00208-w",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.1001/jama.2019.0709",
      "author": "GJ Walker",
      "doi-asserted-by": "publisher",
      "first-page": "773",
      "journal-title": "JAMA",
      "key": "2628_CR46",
      "unstructured": "Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC, Beaugerie L, Bewshea CM (2019) Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease. JAMA 321:773–785",
      "volume": "321",
      "year": "2019"
    },
    {
      "DOI": "10.5694/mja2.51759",
      "author": "C White",
      "doi-asserted-by": "publisher",
      "first-page": "510",
      "journal-title": "Med J Aust",
      "key": "2628_CR47",
      "unstructured": "White C, Scott R, Paul CL, Ackland SP (2022) Pharmacogenomics in the era of personalised medicine. Med J Aust 217:510–513. https://doi.org/10.5694/mja2.51759",
      "volume": "217",
      "year": "2022"
    },
    {
      "DOI": "10.1007/BF03261973",
      "author": "C Wu",
      "doi-asserted-by": "publisher",
      "first-page": "769",
      "journal-title": "Drug Saf",
      "key": "2628_CR48",
      "unstructured": "Wu C, Bell CM, Wodchis WP (2012) Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf 35:769–781. https://doi.org/10.1007/BF03261973",
      "volume": "35",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs-2017-0033",
      "author": "Y Yang",
      "doi-asserted-by": "publisher",
      "first-page": "673",
      "journal-title": "Pharmacogenomics",
      "key": "2628_CR49",
      "unstructured": "Yang Y, Botton MR, Scott ER, Scott SA (2017) Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing. Pharmacogenomics 18:673–685",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1111/bcp.14704",
      "author": "E Youssef",
      "doi-asserted-by": "publisher",
      "first-page": "2907",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2628_CR50",
      "unstructured": "Youssef E, Kirkdale CL, Wright DJ, Guchelaar HJ, Thornley T (2021) Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK. Br J Clin Pharmacol 87:2907–2925. https://doi.org/10.1111/bcp.14704",
      "volume": "87",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pgen.1009323",
      "author": "MHC Yu",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS Genet",
      "key": "2628_CR51",
      "unstructured": "Yu MHC, Chan MCY, Chung CCY, Li AWT, Yip CYW, Mak CCY, Chau JFT, Lee M, Fung JLF, Tsang MHY (2021) Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population. PLoS Genet 17:e1009323",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s00439-021-02385-x",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "1113",
      "journal-title": "Hum Genet",
      "key": "2628_CR52",
      "unstructured": "Zhou Y, Lauschke VM (2022) Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health. Hum Genet 141:1113–1136. https://doi.org/10.1007/s00439-021-02385-x",
      "volume": "141",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41436-020-00995-w",
      "author": "Y Zhu",
      "doi-asserted-by": "publisher",
      "first-page": "461",
      "journal-title": "Genet Med",
      "key": "2628_CR53",
      "unstructured": "Zhu Y, Moriarty JP, Swanson KM, Takahashi PY, Bielinski SJ, Weinshilboum R, Wang L, Borah BJ (2021) A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none? Genet Med 23:461–470. https://doi.org/10.1038/s41436-020-00995-w",
      "volume": "23",
      "year": "2021"
    }
  ],
  "reference-count": 53,
  "references-count": 53,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.21203/rs.3.rs-2574590/v1",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s00439-023-02628-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum. Genet."
  ],
  "source": "Crossref",
  "title": [
    "Mining local exome and HLA data to characterize pharmacogenetic variants in Saudi Arabia"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "143"
}